In an observational study, individuals that have T2DM, GLP-1RA therapy, Liraglutide, reduced pro-inflammatory cytokines (e.g., TNF-, interleukin-1 beta (IL-1), IL-6) in PBMCs, and increased serum adipokine, adiponectin, and macrophage activation markers (sCD163) [95]
This protocol should only be used under professional guidance
Synthesizing this data into actionable dosing protocols requires understanding the context behind each number
injection: Timing differences One of the most common questions is how oral BPC capsules compare with injectable BPC-157 and what that means for timing
Tackling the Food Sustainability Crisis: Meet ALOHA, the First Food Brand to Use Ponova Oil Sustainability has become the centerpiece of conversations surrounding the future of food and, as usual, was a major talking point and product feature at Expo West 2024